Image Analysis
Visiopharm continues to make news this year with appointment of Patrik Dahlén to its Board of Directors as Chairman. Today Visiopharm announces that Patrik Dahlén, previously the CEO of Dako, has joined the Visiopharm Board of Directors as...
The scanning of slides into whole slide images (WSI) is the just the first step on the journey of quantitative digital pathology; a journey in which hypotheses can be tested, derived and ultimately deliver both qualitative and quantitative...
Seattle-based scientific imaging startup Glencoe Software today announced a $800,000 seed investment round led by TIE Angels Group Seattle. Glencoe Software is a 10-year-old company that helps researchers in the biopharma and...
Speedy Stereology microDimensions, global provider of the world’s most powerful 3D histology reconstruction software Voloom®, has added Outspace™ to its digital pathology image analysis portfolio, the fastest and most easy-to-use...
Assessment of relevant quantitative data from tumors by histology is a cornerstone of cancer research and diagnostics. Today it is a challenge to understand, define and quantify tumor heterogeneity in a way that has practical utility for...
Two great career opportunities are now available with Visiopharm in the United States to expand our dedicated, North American team. The first position is for a Regional Director of Sales, specializing in the Biopharmaceutical market and based...
